About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

TERMINATEDPhase 4

A Study to Determine the Best Dose of Antivirals in Patients With Both TB and HIV

NCT00523458•Stanford University

View on ClinicalTrials.gov

AI summary by Clareo Health

Generating AI summary...

Conditions

HIV InfectionsTuberculosis

Interventions

efavirenz or nevirapine

Locations

1

Brazil

Locations (1)

Hospital Universitario Prof. Edgard Santos/Universidade Federal da Bahia

Salvador, Estado de Bahia, Brazil

Key Dates

Start Date

July 1, 2007

Primary Completion Date

March 1, 2008

Completion Date

March 1, 2008

Last Updated

July 22, 2011

Related Studies

RECRUITINGPhase 2

Trial of Novel Regimens for the Treatment of Pulmonary Tuberculosis

NCT06192160

Pulmonary Tuberculosis

RECRUITINGPhase 2

Evaluating the Safety and Immunogenicity of MTBVAC

NCT05947890

HIV I InfectionTuberculosis

Rapid Research in Diagnostics Development for TB Network (R2D2 Kids) and Assessing Diagnostics At POC for TB in Children (ADAPT for Kids)

NCT05989802

TuberculosisDiagnostics+1 more

Skeletal Muscle Energetics and Fatiguability in Older Individuals

NCT04142047

HIVHIV Infections

RECRUITINGPhase 3

A Study to Evaluate the Effectiveness of Long-acting (LA) Cabotegravir (CAB) + Rilpivirine (RPV) LA When Given to Participants With Detectable HIV-1

NCT06694805

RECRUITINGPhase 2

A Study to Evaluate the Efficacy, Safety and Immunogenicity of MTBVAC in Adolescents and Adults Living in a TB Endemic Region.

NCT06272812

Tuberculosis (TB)

View all related studies

Sponsors

Lead Sponsor

Stanford University

Detailed Description

Full Eligibility Criteria

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: July 22, 2011Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions